FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)

View source ↗

Summary

FDA approved a supplemental application for Lantus SoloStar (insulin glargine) submitted by Sanofi-Aventis U.S. LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus SoloStar (Insulin glargine)

Snippet

SUPPL AP for LANTUS SOLOSTAR (INSULIN GLARGINE)